![]() |
|
|
Vol. 301, Issue 3, 993-1002, June 2002
Department of Psychiatry, University of Minnesota, Minneapolis,
Minnesota
There is increasing evidence that
-opioid receptor agonists
modulate cocaine-maintained behavior, and limited findings implicate the involvement of
-opioid receptors in ethanol-maintained
behaviors. The purpose of the present study was to investigate the
effects of bremazocine, a
-opioid agonist, on the
self-administration of smoked cocaine base and oral ethanol in rhesus
monkeys (Macaca mulatta). To determine the selectivity
of bremazocine, the effects of bremazocine pretreatment on the oral
self-administration of phencyclidine (PCP), saccharin, and food were
also examined. Adult male rhesus monkeys were trained to
self-administer oral ethanol, PCP, saccharin (n = 8), food (n = 6), or smoked cocaine base
(n = 6) and water during daily sessions.
Bremazocine (0.00032-, 0.001-, and 0.0025-mg/kg i.m.) injections were
given 15 min before session. The 4 days of stable behavior before
pretreatment served as baseline. Demand curves (consumption × fixed ratio; FR) were obtained for smoked cocaine base, ethanol, and
PCP by varying the cost (FR) of drug deliveries and measuring
consumption (deliveries). Bremazocine (0.001 mg/kg) was administered at
each FR value in nonsystematic order. Results indicate that bremazocine
dose dependently reduced cocaine, ethanol, PCP, and saccharin intake.
Food intake was affected less by bremazocine than the other substances
in five of the six monkeys. Generally, bremazocine treatment reduced
the demand for cocaine, ethanol, and PCP as well as other measures of
response strength. These results extend the findings that
-agonists
reduce the self-administration of drug and nondrug reinforcers to
smoked cocaine base and oral ethanol, PCP, and saccharin in rhesus monkeys.